Ocugen Inc
OCGN1.000USD
+0.006+0.61%
交易中 （美东）报价延迟15分钟
291.94M总市值
亏损市盈率 TTM
关于 Ocugen Inc 公司
Ocugen, Inc. 是一家生物制药公司。该公司专注于发现、开发和商业化基因和细胞疗法、生物制剂和疫苗，以改善全球患者的健康。其技术管道包括修饰基因治疗平台、再生医学细胞治疗平台和视网膜疾病的生物疗法。该公司正在开发其修饰基因治疗平台，包括 OCU400、OCU410 和 OCU410ST，用于治疗多种遗传性视网膜疾病 (IRD)，包括视网膜色素变性 (RP)、莱伯先天性黑蒙 (LCA)、Stargardt 病和多因素疾病，如干性年龄相关性黄斑变性 (dAMD) 和地图状萎缩 (GA)。它正在开发基于新型 ChAd 载体的吸入式粘膜疫苗平台，其中包括 OCU500（一种 COVID-19 疫苗）；OCU510（一种季节性四价流感疫苗）；以及 OCU520，一种四价季节性流感和 COVID-19 联合疫苗。
公司简介
公司代码OCGN
公司名称Ocugen Inc
上市日期Dec 03, 2014
CEODr. Shankar Musunuri, Ph.D.
员工数量95
证券类型Ordinary Share
年结日Dec 03
公司地址11 Great Valley Parkway
城市MALVERN
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编19355
电话14843284701
网址https://ocugen.com/
公司代码OCGN
上市日期Dec 03, 2014
CEODr. Shankar Musunuri, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.17M
+0.01%
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer, Head of Research and Development
Chief Scientific Officer, Head of Research and Development
214.50K
+250.87%
Ms. Kirsten Castillo
Ms. Kirsten Castillo
Independent Director
Independent Director
75.00K
+50.00%
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
1.80K
--
Ms. Tiffany Hamilton
Ms. Tiffany Hamilton
Head of Communications
Head of Communications
--
--
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Huma Qamar, M.D.
Dr. Huma Qamar, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Uday B. Kompella, Ph.D.
Dr. Uday B. Kompella, Ph.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.17M
+0.01%
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer, Head of Research and Development
Chief Scientific Officer, Head of Research and Development
214.50K
+250.87%
Ms. Kirsten Castillo
Ms. Kirsten Castillo
Independent Director
Independent Director
75.00K
+50.00%
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
1.80K
--
Ms. Tiffany Hamilton
Ms. Tiffany Hamilton
Head of Communications
Head of Communications
--
--
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
收入明细
FY2025Q1
FY2024
FY2023
FY2021
FY2020
暂无数据
地区USD
名称
营收
占比
United States
1.48M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
6.24%
The Vanguard Group, Inc.
5.71%
Geode Capital Management, L.L.C.
2.36%
State Street Global Advisors (US)
2.03%
GMT Capital Corp.
1.42%
Other
82.24%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
6.24%
The Vanguard Group, Inc.
5.71%
Geode Capital Management, L.L.C.
2.36%
State Street Global Advisors (US)
2.03%
GMT Capital Corp.
1.42%
Other
82.24%
股东类型
持股股东
占比
Investment Advisor
15.79%
Investment Advisor/Hedge Fund
6.52%
Hedge Fund
3.35%
Individual Investor
1.21%
Research Firm
0.74%
Corporation
0.39%
Bank and Trust
0.17%
Pension Fund
0.02%
Other
71.80%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
267
82.38M
28.21%
-9.38M
2025Q1
278
81.07M
27.89%
-11.63M
2024Q4
292
76.62M
26.34%
-21.25M
2024Q3
306
84.66M
29.43%
-6.14M
2024Q2
300
72.04M
27.84%
+19.28M
2024Q1
302
36.88M
14.47%
-15.26M
2023Q4
300
30.54M
12.06%
-31.79M
2023Q3
314
37.28M
14.69%
-34.75M
2023Q2
332
53.23M
20.91%
-28.29M
2023Q1
336
68.93M
30.49%
-36.35M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
18.22M
6.24%
-377.91K
-2.03%
Mar 31, 2025
The Vanguard Group, Inc.
16.68M
5.71%
+64.02K
+0.39%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.89M
2.36%
+300.41K
+4.56%
Mar 31, 2025
State Street Global Advisors (US)
5.93M
2.03%
+65.93K
+1.12%
Mar 31, 2025
GMT Capital Corp.
4.15M
1.42%
+1.70M
+69.20%
Mar 31, 2025
UBS Financial Services, Inc.
4.15M
1.42%
+3.42M
+469.31%
Mar 31, 2025
Renaissance Technologies LLC
3.46M
1.18%
+1.37M
+65.70%
Mar 31, 2025
Northern Trust Investments, Inc.
2.30M
0.79%
-103.69K
-4.31%
Mar 31, 2025
GSA Capital Partners LLP
1.64M
0.56%
+492.30K
+42.97%
Mar 31, 2025
Musunuri (Shankar Ph.D)
1.34M
0.46%
+607.32K
+82.50%
Apr 14, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.52%
iShares Micro-Cap ETF
0.01%
Pacer WealthShield ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比0.52%
iShares Micro-Cap ETF
占比0.01%
Pacer WealthShield ETF
占比0%
iShares Russell 2000 ETF
占比0%
ProShares UltraPro Russell2000
占比0%
ProShares Hedge Replication ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
Global X Russell 2000 ETF
占比0%
Proshares Ultra Russell 2000
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
